I initially trained at the University of Cambridge in the life sciences (cell biology, immunology, virology; PhD) and later at the London School of Hygiene & Tropical Medicine (epidemiology, MSc). I am now a group leader in infectious diseases and observational epidemiological studies, within the Department of Infectious Disease Epidemiology.
Non-adherence to anti-TB treatment is temporally complex, increases across the treatment course, and is the result of the intersection of multifaceted day-to-day events in an individual’s life, with complicated implications for effective drug levels across the treatment course. This complexity substantially limits our ability to predict an individual’s non-adherence at the start of treatment.Joint first authors- Tuwabunze and SalimJoint senior authors- Mpagama and Stagg
Source: Conference 2024